Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction

Biomaterials

Volumn 35, Issue 30, 2014, Pages 8528-8539

  Vandergriff, Adam C ^a,b   Hensley, Taylor M ^a   Henry, Eric T ^a,b   Shen, Deliang ^c   Anthony, Shirena ^a   Zhang, Jinying ^c   Cheng, Ke ^a,b,d  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Biomedical Research Imaging Center   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Cardiac stem cells; Ferumoxytol; Magnetic targeting; MRI; Myocardial infarction; Superparamagnetic iron oxide nanoparticles

Indexed keywords

CYTOLOGY; HEART; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; POLYMERASE CHAIN REACTION; RATS; STEM CELLS;

CARDIAC STEM CELLS; FERUMOXYTOL; MAGNETIC TARGETING; MYOCARDIAL INFARCTION; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;

NANOMAGNETICS;

FERRIC FERROCYANIDE; FERRITIN; FERUMOXYTOL; HEPARIN; NANOPARTICLE; PROTAMINE; TRANSFERRIN; TROPONIN I; MAGNETITE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CARDIOSPHERE DERIVED STEM CELL; CARDITIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DISEASE EXACERBATION; DRUG LABELING; ECHOCARDIOGRAPHY; ENGRAFTMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; FLUORESCENCE IMAGING; HEART EJECTION FRACTION; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON OVERLOAD; MAGNET; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; STEM CELL; TRANSFERRIN BLOOD LEVEL; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; FINITE ELEMENT ANALYSIS; HEART MUSCLE; INFLAMMATION; MAGNETISM; MULTICELLULAR SPHEROID; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; ULTRASTRUCTURE; WISTAR KYOTO RAT;

RATTUS;

ANIMALS; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; FERROSOFERRIC OXIDE; FINITE ELEMENT ANALYSIS; HEART FUNCTION TESTS; HEPARIN; HUMANS; INFLAMMATION; IRON OVERLOAD; MAGNETIC PHENOMENA; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTAMINES; RATS; RATS, INBRED WKY; SPHEROIDS, CELLULAR;

EID: 84904768512     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.06.031     Document Type: Article

References (22)

1. Wollert K.C., Drexler H. Clinical applications of stem cells for the heart. Circ Res 2005, 96:151-163.
2. Al Kindi A., Ge Y., Shum-Tim D., Chiu R.C. Cellular cardiomyoplasty: routes of cell delivery and retention. Front Biosci 2008, 13:2421-2434.
3. Terrovitis J.V., Smith R.R., Marbán E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106:479-494.
4. Cheng K., Li T.S., Malliaras K., Davis D.R., Zhang Y., Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106:1570-1581.
5. Cheng K., Malliaras K., Li T.S., Sun B., Houde C., Galang G., et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant 2012, 21:1121-1135.
6. Huang Z., Pei N., Wang Y., Xie X., Sun A., Shen L., et al. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials 2010, 31:2130-2140.
7. Huang Z., Shen Y., Pei N., Sun A., Xu J., Song Y., et al. The effiect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation. Biomaterials 2013, 34:9905-9916.
8. Huang Z., Shen Y., Sun A., Huang G., Zhu H., Huang B., et al. Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. Stem Cell Res Ther 2013, 4:149.
9. Polyak B., Fishbein I., Chorny M., Alferiev I., Williams D., Yellen B., et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc Natl Acad Sci USA 2008, 105:698-703.
10. Thu M.S., Bryant L.H., Coppola T., Jordan E.K., Budde M.D., Lewis B.K., et al. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med 2012, 18:463-467.
11. Makkar R.R., Smith R.R., Cheng K., Malliaras K., Thomson L.E., Berman D., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
12. Li T.S., Cheng K., Malliaras K., Smith R.R., Zhang Y., Sun B., et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 2012, 59:942-953.
13. Dykstra M.J. Materials and methods for EM samples. A manual of applied techniques for biological electron microscopy 1998, 257. Plenum Press, New York.
14. Cheng K., Blusztajn A., Shen D., Li T.S., Sun B., Galang G., et al. Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. Biomaterials 2012, 33:5317-5324.
15. Terrovitis J., Stuber M., Youssef A., Preece S., Leppo M., Kizana E., et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008, 117:1555-1562.
16. Chimenti I., Smith R.R., Li T.-S., Gerstenblith G., Messina E., Giacomello A., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010, 106:971-980.
17. Marban E., Cheng K. Heart to heart: the elusive mechanism of cell therapy. Circulation 2010, 121:1981-1984.
18. Lu M., Cohen M.H., Rieves D., Pazdur R. FDA report: ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease. Am J Hematol 2010, 85:315-319.
19. Dósa E., Tuladhar S., Muldoon L.L., Hamilton B.E., Rooney W.D., Neuwelt E.A. MRI using ferumoxytol improves the visualization of central nervous system vascular malformations. Stroke 2011, 42:1581-1588.
20. Gutova M., Frank J.A., D'Apuzzo M., Khankaldyyan V., Gilchrist M.M., Annala A.J., et al. Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use. Stem Cells Transl Med 2013, 2:766-775.
21. Shen D., Cheng K., Marban E. Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. J Cell Mol Med 2012, 16:2112-2116.
22. Filgueiras-Rama D., Estrada A., Shachar J., Castrejón S., Doiny D., Ortega M., et al. Remote magnetic navigation for accurate, real-time catheter positioning and ablation in cardiac electrophysiology procedures. Vis Exp 2013, 74:3658.